{"id":2382,"date":"2024-01-27T13:09:28","date_gmt":"2024-01-27T21:09:28","guid":{"rendered":"https:\/\/puny-toaster.flywheelstaging.com\/?p=2382"},"modified":"2026-09-19T19:48:37","modified_gmt":"2026-09-20T02:48:37","slug":"avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2","status":"publish","type":"post","link":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/","title":{"rendered":"Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant"},"content":{"rendered":"<p>RealLIST Startups 2020 honoree Avisi Technologies, maker of an ocular implant to treat glaucoma, is the recent recipient of a $1 million Small Business Innovation Research Phase II grant from the National Science Foundation (NSF) \u2014 funds cofounder Rui Jing Jiang said will go toward bringing the startup\u2019s research to life in preclinical work.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>RealLIST Startups 2020 honoree Avisi Technologies, maker of an ocular implant to treat glaucoma, is the recent recipient of a $1 million Small Business Innovation Research Phase II grant from the National Science Foundation (NSF) \u2014 funds cofounder Rui Jing Jiang said will go toward bringing the startup\u2019s research to life in preclinical work.<\/p>\n","protected":false},"author":486,"featured_media":1048,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[152,150],"tags":[],"class_list":["post-2382","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innovation","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant - Avisi Technologies Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant - Avisi Technologies Inc.\" \/>\n<meta property=\"og:description\" content=\"RealLIST Startups 2020 honoree Avisi Technologies, maker of an ocular implant to treat glaucoma, is the recent recipient of a $1 million Small Business Innovation Research Phase II grant from the National Science Foundation (NSF) \u2014 funds cofounder Rui Jing Jiang said will go toward bringing the startup\u2019s research to life in preclinical work.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Avisi Technologies Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-27T21:09:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-20T02:48:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/avisitech.com\/wp-content\/uploads\/2024\/01\/SBIR.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1257\" \/>\n\t<meta property=\"og:image:height\" content=\"839\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ivankornienko\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ivankornienko\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/\"},\"author\":{\"name\":\"ivankornienko\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#\\\/schema\\\/person\\\/8912f5bbc34efc0fee96277c64d105a5\"},\"headline\":\"Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant\",\"datePublished\":\"2024-01-27T21:09:28+00:00\",\"dateModified\":\"2026-09-20T02:48:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/\"},\"wordCount\":65,\"publisher\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/SBIR.png\",\"articleSection\":[\"Innovation\",\"News\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/\",\"url\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/\",\"name\":\"Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant - Avisi Technologies Inc.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/SBIR.png\",\"datePublished\":\"2024-01-27T21:09:28+00:00\",\"dateModified\":\"2026-09-20T02:48:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/SBIR.png\",\"contentUrl\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/SBIR.png\",\"width\":1257,\"height\":839},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#website\",\"url\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/\",\"name\":\"Avisi Technologies Inc.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#organization\",\"name\":\"Avisi Technologies Inc.\",\"url\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Avisi-Technologies-Logo-SVG-Final-1.svg\",\"contentUrl\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Avisi-Technologies-Logo-SVG-Final-1.svg\",\"width\":124,\"height\":43,\"caption\":\"Avisi Technologies Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#\\\/schema\\\/person\\\/8912f5bbc34efc0fee96277c64d105a5\",\"name\":\"ivankornienko\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g\",\"caption\":\"ivankornienko\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant - Avisi Technologies Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/","og_locale":"ja_JP","og_type":"article","og_title":"Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant - Avisi Technologies Inc.","og_description":"RealLIST Startups 2020 honoree Avisi Technologies, maker of an ocular implant to treat glaucoma, is the recent recipient of a $1 million Small Business Innovation Research Phase II grant from the National Science Foundation (NSF) \u2014 funds cofounder Rui Jing Jiang said will go toward bringing the startup\u2019s research to life in preclinical work.","og_url":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/","og_site_name":"Avisi Technologies Inc.","article_published_time":"2024-01-27T21:09:28+00:00","article_modified_time":"2026-09-20T02:48:37+00:00","og_image":[{"width":1257,"height":839,"url":"https:\/\/avisitech.com\/wp-content\/uploads\/2024\/01\/SBIR.png","type":"image\/png"}],"author":"ivankornienko","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ivankornienko"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/#article","isPartOf":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/"},"author":{"name":"ivankornienko","@id":"https:\/\/avisitech.com\/ja\/#\/schema\/person\/8912f5bbc34efc0fee96277c64d105a5"},"headline":"Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant","datePublished":"2024-01-27T21:09:28+00:00","dateModified":"2026-09-20T02:48:37+00:00","mainEntityOfPage":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/"},"wordCount":65,"publisher":{"@id":"https:\/\/avisitech.com\/ja\/#organization"},"image":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/#primaryimage"},"thumbnailUrl":"https:\/\/avisitech.com\/wp-content\/uploads\/2024\/01\/SBIR.png","articleSection":["Innovation","News"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/","url":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/","name":"Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant - Avisi Technologies Inc.","isPartOf":{"@id":"https:\/\/avisitech.com\/ja\/#website"},"primaryImageOfPage":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/#primaryimage"},"image":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/#primaryimage"},"thumbnailUrl":"https:\/\/avisitech.com\/wp-content\/uploads\/2024\/01\/SBIR.png","datePublished":"2024-01-27T21:09:28+00:00","dateModified":"2026-09-20T02:48:37+00:00","breadcrumb":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/#primaryimage","url":"https:\/\/avisitech.com\/wp-content\/uploads\/2024\/01\/SBIR.png","contentUrl":"https:\/\/avisitech.com\/wp-content\/uploads\/2024\/01\/SBIR.png","width":1257,"height":839},{"@type":"BreadcrumbList","@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-eyes-goal-of-human-trials-with-1m-national-science-foundation-grant-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/avisitech.com\/ja\/"},{"@type":"ListItem","position":2,"name":"Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant"}]},{"@type":"WebSite","@id":"https:\/\/avisitech.com\/ja\/#website","url":"https:\/\/avisitech.com\/ja\/","name":"Avisi Technologies Inc.","description":"","publisher":{"@id":"https:\/\/avisitech.com\/ja\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/avisitech.com\/ja\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/avisitech.com\/ja\/#organization","name":"Avisi Technologies Inc.","url":"https:\/\/avisitech.com\/ja\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/avisitech.com\/ja\/#\/schema\/logo\/image\/","url":"https:\/\/avisitech.com\/wp-content\/uploads\/2024\/01\/Avisi-Technologies-Logo-SVG-Final-1.svg","contentUrl":"https:\/\/avisitech.com\/wp-content\/uploads\/2024\/01\/Avisi-Technologies-Logo-SVG-Final-1.svg","width":124,"height":43,"caption":"Avisi Technologies Inc."},"image":{"@id":"https:\/\/avisitech.com\/ja\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/avisitech.com\/ja\/#\/schema\/person\/8912f5bbc34efc0fee96277c64d105a5","name":"ivankornienko","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/secure.gravatar.com\/avatar\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g","caption":"ivankornienko"}}]}},"_links":{"self":[{"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/posts\/2382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/users\/486"}],"replies":[{"embeddable":true,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/comments?post=2382"}],"version-history":[{"count":1,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/posts\/2382\/revisions"}],"predecessor-version":[{"id":2384,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/posts\/2382\/revisions\/2384"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/media\/1048"}],"wp:attachment":[{"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/media?parent=2382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/categories?post=2382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/tags?post=2382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}